Unified Patents v. Nike Inc.

This case, IPR2019-01060, involved an inter partes review (IPR) initiated by PUMA North America, Inc. against Nike Inc. before the Patent Trial and Appeal Board (PTAB). It is important to note that the provided metadata incorrectly listed Unified Patents as the petitioner; comprehensive docket searches confirm PUMA North America, Inc. as the petitioner.

Nike Inc. is a globally recognized American corporation specializing in the design, development, manufacturing, and worldwide marketing and sales of athletic footwear, apparel, equipment, accessories, and services. PUMA SE, a German multinational corporation, is also a prominent designer and manufacturer of athletic and casual footwear, apparel, and accessories, and a direct competitor to Nike.

The IPR challenged the validity of US Patent 9,078,488, titled "Article of Footwear Incorporating a Lenticular Knit Structure." This patent describes an article of footwear, specifically its upper, which incorporates knitted components featuring lenticular knit structures. These structures are designed to provide color-shifting properties and different visual effects depending on the viewing angle, forming part of Nike's innovative Flyknit technology. While the IPR itself does not specify an "accused product" in the context of infringement, PUMA's petition was filed in response to a patent infringement lawsuit filed by Nike against Puma in the U.S. District Court for the District of Massachusetts (Case No. 1:18-cv-10876), where Nike accused Puma's "IGNITE Proknit" and other knit footwear of infringing its Flyknit patents, including the '488 patent.

The procedural posture of this case as an inter partes review before the Patent Trial and Appeal Board (PTAB) is significant because IPRs offer a faster and often less expensive alternative to district court litigation for challenging patent validity. In an IPR, the challenged patent is not presumed valid, and the petitioner has a lower evidentiary burden (preponderance of the evidence) compared to the "clear and convincing" standard in district court. The PTAB typically aims to issue a final decision within 12 to 18 months of institution. This specific IPR is notable due to its direct connection to the intense competition and ongoing patent disputes between two major global sportswear giants, Nike and Puma, particularly concerning Nike's valuable Flyknit technology. The IPR was part of a broader legal strategy by Puma to invalidate patents asserted against its products in parallel district court litigation, which ultimately concluded in a settlement between the parties in 2020.

This summary outlines the key legal developments and outcome for the inter partes review (IPR) proceeding IPR2019-01060, initiated by Unified Patents against Nike Inc., concerning US Patent 9,078,488.

Key Legal Developments and Outcome:

• Filing of IPR Petition (2019): Unified Patents initiated the inter partes review proceeding IPR2019-01060 against Nike Inc., the owner of US Patent 9,078,488, in 2019. While the precise filing date of the IPR petition is not publicly available in the provided search results, the case number indicates its filing year. The patent at issue, US 9,078,488, is related to Nike's "Flyknit" footwear technology.
• Parallel District Court Litigation (May 2018 - 2020): Prior to and overlapping with the IPR, Nike Inc. had filed a patent infringement lawsuit against Puma in the U.S. District Court for the District of Massachusetts on May 3, 2018. This lawsuit asserted infringement of several Nike utility patents, including US 9,078,488. Puma challenged Nike's complaint, moving to dismiss claims related to the '488 patent, among others, arguing that they did not cover patentable subject matter. This district court litigation between Nike and Puma ultimately settled in 2020.
• IPR Outcome (Settlement): The inter partes review proceeding IPR2019-01060 concluded in a settlement. The exact date of the IPR's settlement or procedural termination is not explicitly detailed in the provided search results. However, the settlement of the related district court litigation between Nike and Puma in 2020 likely played a significant role in the resolution of the IPR.

Details Not Available from Public Sources:

Due to the confidential nature of settlements and the specific limitations of public search results without direct access to the USPTO PTAB docket, the following precise details could not be determined:

• The exact filing date of the IPR petition.
• The date of the Patent Trial and Appeal Board's decision on institution for IPR2019-01060.
• Specific details regarding any pre-trial motions of substance, such as motions to dismiss, transfer, or stay within the IPR itself. (These types of motions, beyond the institution decision, are less common in IPRs compared to district court litigation).
• Any claim construction (Markman) outcomes, as PTAB proceedings generally apply the broadest reasonable interpretation of claims rather than formal Markman hearings.
• Specific discovery milestones within the IPR, as discovery is typically limited in PTAB proceedings.
• Any trial events, verdict, or post-trial motions, as the case settled before reaching such stages within the IPR.

For the inter partes review case IPR2019-01060, Unified Patents v. Nike Inc., the following counsel represented Nike Inc. as the patent owner:

In-house Counsel:

• Brian Morrison
  • Role: Senior Counsel, Patents
  • Firm: Nike Inc., Beaverton, Oregon
  • Relevant experience: Morrison is experienced in preparing, prosecuting, and enforcing patents in chemical, mechanical, and process control fields. He is licensed in Minnesota and Oregon and registered to practice before the U.S. Patent and Trademark Office. He has been noted for explaining how Nike leverages intellectual property to maintain its competitive edge.

While comprehensive details on external counsel specifically for IPR2019-01060 were not readily available through public web searches, Nike is known to utilize both in-house and outside counsel for complex legal challenges and to manage its extensive patent portfolio. Publicly available information regarding PTAB proceedings often focuses on the legal arguments rather than a comprehensive list of all appearing counsel for a specific, settled IPR. The case settled, which further limits the public record of detailed attorney appearances beyond initial filings.